Global Pharmaceutical Intermediates
Global Pharmaceutical Intermediates

Pharmaceutical Intermediates Comprehensive Study by Application (Antibiotics, Antipyretic Analgesics, Vitamins, Others), End-User (Pharmaceutical Organizations, Research Labs, Biotechnology & Life Sciences), Quality Type (Moderate, High Quality, Premium), Grade Type (Industrial Grade, Pharmaceutical Grade) Players and Region - Global Market Outlook to 2025

Pharmaceutical Intermediates Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Apr 2020 Edition 208 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study

Intermediates refer to semi-finished products, is the intermediate products of some products these are fine chemical products. For example it is used to produce a product, it can be produced from intermediates to save costs. Drug production involves a large number of special chemicals, most of them were formerly produced by the pharmaceutical industry, but with the deepening of social labor separation and the development of production technology, the pharmaceutical industry will transfer the production of some pharmaceutical intermediates to chemical enterprises. The production of pharmaceutical intermediates has become a main industry in the worldwide chemical industry.

The market study is being classified, by Application (Antibiotics, Antipyretic Analgesics, Vitamins and Others) and major geographies with country level break-up.

A.R. Life Sciences Private Limited (India), Vertellus Holdings LLC (United States), Lianhetech (China), Dishman Group (India), Midas Pharma GmbH (Germany), Codexis, Inc. (United States), Chemcon Specialty Chemicals Pvt. Ltd (India), Aceto Corporation (United States), Cycle Pharma (United Kingdom), Dextra Laboratories Ltd. (United Kingdom), BASF SE (Germany) and Sanofi Winthrop Industrie S.A. (France) are some of the key players profiled in the study. Additionally, the Vendors which are also part of the research are ZCL Chemicals Ltd. (India), Easter Chemical Corporation (United States) and Anyang General Chemical Co., Ltd. (China).

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Asian and United States Vendors will contribute to the maximum growth of Global Pharmaceutical Intermediates market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Pharmaceutical Intermediates market by Type, Application and Region.

On the basis of geography, the market of Pharmaceutical Intermediates has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increased Problem of Various Diseases Such As Infectious Diseases, Chronic Diseases
  • Various Research and Development Activities Carried By Pharmaceutical Companies

Market Trend
  • Patent Expiry Is Also a Major Factor Supporting the Growth of the Pharmaceutical Intermediate

Restraints
  • Stringent Regulatory Policies on Pharmaceutical Intermediate

Opportunities
  • High Spending On Research and Development Activities





Key Target Audience
Manufacturers of Pharmaceutical Intermediate, Suppliers of Pharmaceutical Intermediate, Wholesalers, Distributors and Retailers of Pharmaceutical Intermediate, Chemical Industry, Pharmaceutical Industry, Regulatory Bodies and Governmental Bodies

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Application
  • Antibiotics
  • Antipyretic Analgesics
  • Vitamins
  • Others
By End-User
  • Pharmaceutical Organizations
  • Research Labs
  • Biotechnology & Life Sciences

By Quality Type
  • Moderate
  • High Quality
  • Premium

By Grade Type
  • Industrial Grade
  • Pharmaceutical Grade

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Problem of Various Diseases Such As Infectious Diseases, Chronic Diseases
      • 3.2.2. Various Research and Development Activities Carried By Pharmaceutical Companies
    • 3.3. Market Trends
      • 3.3.1. Patent Expiry Is Also a Major Factor Supporting the Growth of the Pharmaceutical Intermediate
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pharmaceutical Intermediates, by Application, End-User, Quality Type, Grade Type and Region (value, volume and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Pharmaceutical Intermediates (Value)
      • 5.2.1. Global Pharmaceutical Intermediates by: Application (Value)
        • 5.2.1.1. Antibiotics
        • 5.2.1.2. Antipyretic Analgesics
        • 5.2.1.3. Vitamins
        • 5.2.1.4. Others
      • 5.2.2. Global Pharmaceutical Intermediates by: End-User (Value)
        • 5.2.2.1. Pharmaceutical Organizations
        • 5.2.2.2. Research Labs
        • 5.2.2.3. Biotechnology & Life Sciences
      • 5.2.3. Global Pharmaceutical Intermediates by: Quality Type (Value)
        • 5.2.3.1. Moderate
        • 5.2.3.2. High Quality
        • 5.2.3.3. Premium
      • 5.2.4. Global Pharmaceutical Intermediates by: Grade Type (Value)
        • 5.2.4.1. Industrial Grade
        • 5.2.4.2. Pharmaceutical Grade
      • 5.2.5. Global Pharmaceutical Intermediates Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Pharmaceutical Intermediates (Volume)
      • 5.3.1. Global Pharmaceutical Intermediates by: Application (Volume)
        • 5.3.1.1. Antibiotics
        • 5.3.1.2. Antipyretic Analgesics
        • 5.3.1.3. Vitamins
        • 5.3.1.4. Others
      • 5.3.2. Global Pharmaceutical Intermediates by: End-User (Volume)
        • 5.3.2.1. Pharmaceutical Organizations
        • 5.3.2.2. Research Labs
        • 5.3.2.3. Biotechnology & Life Sciences
      • 5.3.3. Global Pharmaceutical Intermediates by: Quality Type (Volume)
        • 5.3.3.1. Moderate
        • 5.3.3.2. High Quality
        • 5.3.3.3. Premium
      • 5.3.4. Global Pharmaceutical Intermediates by: Grade Type (Volume)
        • 5.3.4.1. Industrial Grade
        • 5.3.4.2. Pharmaceutical Grade
      • 5.3.5. Global Pharmaceutical Intermediates Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Pharmaceutical Intermediates (Price)
  • 6. Pharmaceutical Intermediates: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. A.R. Life Sciences Private Limited (India)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Vertellus Holdings LLC (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Lianhetech (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Dishman Group (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Midas Pharma GmbH (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Codexis, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Chemcon Specialty Chemicals Pvt. Ltd (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Aceto Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Cycle Pharma (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Dextra Laboratories Ltd. (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. BASF SE (Germany)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Sanofi Winthrop Industrie S.A. (France)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Pharmaceutical Intermediates Sale, by Application, End-User, Quality Type, Grade Type and Region (value, volume and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Pharmaceutical Intermediates (Value)
      • 7.2.1. Global Pharmaceutical Intermediates by: Application (Value)
        • 7.2.1.1. Antibiotics
        • 7.2.1.2. Antipyretic Analgesics
        • 7.2.1.3. Vitamins
        • 7.2.1.4. Others
      • 7.2.2. Global Pharmaceutical Intermediates by: End-User (Value)
        • 7.2.2.1. Pharmaceutical Organizations
        • 7.2.2.2. Research Labs
        • 7.2.2.3. Biotechnology & Life Sciences
      • 7.2.3. Global Pharmaceutical Intermediates by: Quality Type (Value)
        • 7.2.3.1. Moderate
        • 7.2.3.2. High Quality
        • 7.2.3.3. Premium
      • 7.2.4. Global Pharmaceutical Intermediates by: Grade Type (Value)
        • 7.2.4.1. Industrial Grade
        • 7.2.4.2. Pharmaceutical Grade
      • 7.2.5. Global Pharmaceutical Intermediates Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Pharmaceutical Intermediates (Volume)
      • 7.3.1. Global Pharmaceutical Intermediates by: Application (Volume)
        • 7.3.1.1. Antibiotics
        • 7.3.1.2. Antipyretic Analgesics
        • 7.3.1.3. Vitamins
        • 7.3.1.4. Others
      • 7.3.2. Global Pharmaceutical Intermediates by: End-User (Volume)
        • 7.3.2.1. Pharmaceutical Organizations
        • 7.3.2.2. Research Labs
        • 7.3.2.3. Biotechnology & Life Sciences
      • 7.3.3. Global Pharmaceutical Intermediates by: Quality Type (Volume)
        • 7.3.3.1. Moderate
        • 7.3.3.2. High Quality
        • 7.3.3.3. Premium
      • 7.3.4. Global Pharmaceutical Intermediates by: Grade Type (Volume)
        • 7.3.4.1. Industrial Grade
        • 7.3.4.2. Pharmaceutical Grade
      • 7.3.5. Global Pharmaceutical Intermediates Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Pharmaceutical Intermediates (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pharmaceutical Intermediates: by Application(USD Million)
  • Table 2. Pharmaceutical Intermediates Antibiotics , by Region USD Million (2014-2019)
  • Table 3. Pharmaceutical Intermediates Antipyretic Analgesics , by Region USD Million (2014-2019)
  • Table 4. Pharmaceutical Intermediates Vitamins , by Region USD Million (2014-2019)
  • Table 5. Pharmaceutical Intermediates Others , by Region USD Million (2014-2019)
  • Table 6. Pharmaceutical Intermediates: by End-User(USD Million)
  • Table 7. Pharmaceutical Intermediates Pharmaceutical Organizations , by Region USD Million (2014-2019)
  • Table 8. Pharmaceutical Intermediates Research Labs , by Region USD Million (2014-2019)
  • Table 9. Pharmaceutical Intermediates Biotechnology & Life Sciences , by Region USD Million (2014-2019)
  • Table 10. Pharmaceutical Intermediates: by Quality Type(USD Million)
  • Table 11. Pharmaceutical Intermediates Moderate , by Region USD Million (2014-2019)
  • Table 12. Pharmaceutical Intermediates High Quality , by Region USD Million (2014-2019)
  • Table 13. Pharmaceutical Intermediates Premium , by Region USD Million (2014-2019)
  • Table 14. Pharmaceutical Intermediates: by Grade Type(USD Million)
  • Table 15. Pharmaceutical Intermediates Industrial Grade , by Region USD Million (2014-2019)
  • Table 16. Pharmaceutical Intermediates Pharmaceutical Grade , by Region USD Million (2014-2019)
  • Table 17. South America Pharmaceutical Intermediates, by Country USD Million (2014-2019)
  • Table 18. South America Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 19. South America Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 20. South America Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 21. South America Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 22. Brazil Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 23. Brazil Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 24. Brazil Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 25. Brazil Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 26. Argentina Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 27. Argentina Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 28. Argentina Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 29. Argentina Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 30. Rest of South America Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 31. Rest of South America Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 32. Rest of South America Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 33. Rest of South America Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 34. Asia Pacific Pharmaceutical Intermediates, by Country USD Million (2014-2019)
  • Table 35. Asia Pacific Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 36. Asia Pacific Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 37. Asia Pacific Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 38. Asia Pacific Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 39. China Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 40. China Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 41. China Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 42. China Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 43. Japan Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 44. Japan Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 45. Japan Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 46. Japan Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 47. India Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 48. India Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 49. India Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 50. India Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 51. South Korea Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 52. South Korea Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 53. South Korea Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 54. South Korea Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 55. Taiwan Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 56. Taiwan Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 57. Taiwan Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 58. Taiwan Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 59. Australia Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 60. Australia Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 61. Australia Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 62. Australia Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 63. Rest of Asia-Pacific Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 64. Rest of Asia-Pacific Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 65. Rest of Asia-Pacific Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 66. Rest of Asia-Pacific Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 67. Europe Pharmaceutical Intermediates, by Country USD Million (2014-2019)
  • Table 68. Europe Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 69. Europe Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 70. Europe Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 71. Europe Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 72. Germany Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 73. Germany Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 74. Germany Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 75. Germany Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 76. France Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 77. France Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 78. France Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 79. France Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 80. Italy Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 81. Italy Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 82. Italy Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 83. Italy Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 84. United Kingdom Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 85. United Kingdom Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 86. United Kingdom Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 87. United Kingdom Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 88. Netherlands Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 89. Netherlands Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 90. Netherlands Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 91. Netherlands Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 92. Rest of Europe Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 93. Rest of Europe Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 94. Rest of Europe Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 95. Rest of Europe Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 96. MEA Pharmaceutical Intermediates, by Country USD Million (2014-2019)
  • Table 97. MEA Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 98. MEA Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 99. MEA Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 100. MEA Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 101. Middle East Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 102. Middle East Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 103. Middle East Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 104. Middle East Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 105. Africa Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 106. Africa Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 107. Africa Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 108. Africa Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 109. North America Pharmaceutical Intermediates, by Country USD Million (2014-2019)
  • Table 110. North America Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 111. North America Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 112. North America Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 113. North America Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 114. United States Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 115. United States Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 116. United States Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 117. United States Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 118. Canada Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 119. Canada Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 120. Canada Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 121. Canada Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 122. Mexico Pharmaceutical Intermediates, by Application USD Million (2014-2019)
  • Table 123. Mexico Pharmaceutical Intermediates, by End-User USD Million (2014-2019)
  • Table 124. Mexico Pharmaceutical Intermediates, by Quality Type USD Million (2014-2019)
  • Table 125. Mexico Pharmaceutical Intermediates, by Grade Type USD Million (2014-2019)
  • Table 126. Pharmaceutical Intermediates Sales: by Application(K Tons)
  • Table 127. Pharmaceutical Intermediates Sales Antibiotics , by Region K Tons (2014-2019)
  • Table 128. Pharmaceutical Intermediates Sales Antipyretic Analgesics , by Region K Tons (2014-2019)
  • Table 129. Pharmaceutical Intermediates Sales Vitamins , by Region K Tons (2014-2019)
  • Table 130. Pharmaceutical Intermediates Sales Others , by Region K Tons (2014-2019)
  • Table 131. Pharmaceutical Intermediates Sales: by End-User(K Tons)
  • Table 132. Pharmaceutical Intermediates Sales Pharmaceutical Organizations , by Region K Tons (2014-2019)
  • Table 133. Pharmaceutical Intermediates Sales Research Labs , by Region K Tons (2014-2019)
  • Table 134. Pharmaceutical Intermediates Sales Biotechnology & Life Sciences , by Region K Tons (2014-2019)
  • Table 135. Pharmaceutical Intermediates Sales: by Quality Type(K Tons)
  • Table 136. Pharmaceutical Intermediates Sales Moderate , by Region K Tons (2014-2019)
  • Table 137. Pharmaceutical Intermediates Sales High Quality , by Region K Tons (2014-2019)
  • Table 138. Pharmaceutical Intermediates Sales Premium , by Region K Tons (2014-2019)
  • Table 139. Pharmaceutical Intermediates Sales: by Grade Type(K Tons)
  • Table 140. Pharmaceutical Intermediates Sales Industrial Grade , by Region K Tons (2014-2019)
  • Table 141. Pharmaceutical Intermediates Sales Pharmaceutical Grade , by Region K Tons (2014-2019)
  • Table 142. South America Pharmaceutical Intermediates Sales, by Country K Tons (2014-2019)
  • Table 143. South America Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 144. South America Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 145. South America Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 146. South America Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 147. Brazil Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 148. Brazil Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 149. Brazil Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 150. Brazil Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 151. Argentina Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 152. Argentina Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 153. Argentina Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 154. Argentina Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 155. Rest of South America Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 156. Rest of South America Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 157. Rest of South America Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 158. Rest of South America Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 159. Asia Pacific Pharmaceutical Intermediates Sales, by Country K Tons (2014-2019)
  • Table 160. Asia Pacific Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 161. Asia Pacific Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 162. Asia Pacific Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 163. Asia Pacific Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 164. China Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 165. China Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 166. China Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 167. China Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 168. Japan Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 169. Japan Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 170. Japan Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 171. Japan Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 172. India Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 173. India Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 174. India Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 175. India Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 176. South Korea Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 177. South Korea Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 178. South Korea Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 179. South Korea Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 180. Taiwan Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 181. Taiwan Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 182. Taiwan Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 183. Taiwan Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 184. Australia Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 185. Australia Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 186. Australia Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 187. Australia Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 188. Rest of Asia-Pacific Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 189. Rest of Asia-Pacific Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 190. Rest of Asia-Pacific Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 191. Rest of Asia-Pacific Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 192. Europe Pharmaceutical Intermediates Sales, by Country K Tons (2014-2019)
  • Table 193. Europe Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 194. Europe Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 195. Europe Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 196. Europe Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 197. Germany Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 198. Germany Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 199. Germany Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 200. Germany Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 201. France Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 202. France Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 203. France Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 204. France Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 205. Italy Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 206. Italy Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 207. Italy Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 208. Italy Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 209. United Kingdom Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 210. United Kingdom Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 211. United Kingdom Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 212. United Kingdom Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 213. Netherlands Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 214. Netherlands Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 215. Netherlands Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 216. Netherlands Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 217. Rest of Europe Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 218. Rest of Europe Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 219. Rest of Europe Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 220. Rest of Europe Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 221. MEA Pharmaceutical Intermediates Sales, by Country K Tons (2014-2019)
  • Table 222. MEA Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 223. MEA Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 224. MEA Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 225. MEA Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 226. Middle East Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 227. Middle East Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 228. Middle East Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 229. Middle East Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 230. Africa Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 231. Africa Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 232. Africa Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 233. Africa Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 234. North America Pharmaceutical Intermediates Sales, by Country K Tons (2014-2019)
  • Table 235. North America Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 236. North America Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 237. North America Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 238. North America Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 239. United States Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 240. United States Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 241. United States Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 242. United States Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 243. Canada Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 244. Canada Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 245. Canada Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 246. Canada Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 247. Mexico Pharmaceutical Intermediates Sales, by Application K Tons (2014-2019)
  • Table 248. Mexico Pharmaceutical Intermediates Sales, by End-User K Tons (2014-2019)
  • Table 249. Mexico Pharmaceutical Intermediates Sales, by Quality Type K Tons (2014-2019)
  • Table 250. Mexico Pharmaceutical Intermediates Sales, by Grade Type K Tons (2014-2019)
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Pharmaceutical Intermediates: by Application(USD Million)
  • Table 264. Pharmaceutical Intermediates Antibiotics , by Region USD Million (2020-2025)
  • Table 265. Pharmaceutical Intermediates Antipyretic Analgesics , by Region USD Million (2020-2025)
  • Table 266. Pharmaceutical Intermediates Vitamins , by Region USD Million (2020-2025)
  • Table 267. Pharmaceutical Intermediates Others , by Region USD Million (2020-2025)
  • Table 268. Pharmaceutical Intermediates: by End-User(USD Million)
  • Table 269. Pharmaceutical Intermediates Pharmaceutical Organizations , by Region USD Million (2020-2025)
  • Table 270. Pharmaceutical Intermediates Research Labs , by Region USD Million (2020-2025)
  • Table 271. Pharmaceutical Intermediates Biotechnology & Life Sciences , by Region USD Million (2020-2025)
  • Table 272. Pharmaceutical Intermediates: by Quality Type(USD Million)
  • Table 273. Pharmaceutical Intermediates Moderate , by Region USD Million (2020-2025)
  • Table 274. Pharmaceutical Intermediates High Quality , by Region USD Million (2020-2025)
  • Table 275. Pharmaceutical Intermediates Premium , by Region USD Million (2020-2025)
  • Table 276. Pharmaceutical Intermediates: by Grade Type(USD Million)
  • Table 277. Pharmaceutical Intermediates Industrial Grade , by Region USD Million (2020-2025)
  • Table 278. Pharmaceutical Intermediates Pharmaceutical Grade , by Region USD Million (2020-2025)
  • Table 279. South America Pharmaceutical Intermediates, by Country USD Million (2020-2025)
  • Table 280. South America Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 281. South America Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 282. South America Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 283. South America Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 284. Brazil Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 285. Brazil Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 286. Brazil Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 287. Brazil Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 288. Argentina Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 289. Argentina Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 290. Argentina Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 291. Argentina Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 292. Rest of South America Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 293. Rest of South America Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 294. Rest of South America Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 295. Rest of South America Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 296. Asia Pacific Pharmaceutical Intermediates, by Country USD Million (2020-2025)
  • Table 297. Asia Pacific Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 298. Asia Pacific Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 299. Asia Pacific Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 300. Asia Pacific Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 301. China Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 302. China Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 303. China Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 304. China Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 305. Japan Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 306. Japan Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 307. Japan Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 308. Japan Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 309. India Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 310. India Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 311. India Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 312. India Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 313. South Korea Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 314. South Korea Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 315. South Korea Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 316. South Korea Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 317. Taiwan Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 318. Taiwan Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 319. Taiwan Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 320. Taiwan Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 321. Australia Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 322. Australia Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 323. Australia Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 324. Australia Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 325. Rest of Asia-Pacific Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 326. Rest of Asia-Pacific Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 327. Rest of Asia-Pacific Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 328. Rest of Asia-Pacific Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 329. Europe Pharmaceutical Intermediates, by Country USD Million (2020-2025)
  • Table 330. Europe Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 331. Europe Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 332. Europe Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 333. Europe Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 334. Germany Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 335. Germany Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 336. Germany Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 337. Germany Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 338. France Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 339. France Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 340. France Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 341. France Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 342. Italy Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 343. Italy Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 344. Italy Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 345. Italy Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 346. United Kingdom Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 347. United Kingdom Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 348. United Kingdom Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 349. United Kingdom Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 350. Netherlands Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 351. Netherlands Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 352. Netherlands Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 353. Netherlands Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 354. Rest of Europe Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 355. Rest of Europe Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 356. Rest of Europe Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 357. Rest of Europe Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 358. MEA Pharmaceutical Intermediates, by Country USD Million (2020-2025)
  • Table 359. MEA Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 360. MEA Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 361. MEA Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 362. MEA Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 363. Middle East Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 364. Middle East Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 365. Middle East Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 366. Middle East Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 367. Africa Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 368. Africa Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 369. Africa Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 370. Africa Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 371. North America Pharmaceutical Intermediates, by Country USD Million (2020-2025)
  • Table 372. North America Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 373. North America Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 374. North America Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 375. North America Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 376. United States Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 377. United States Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 378. United States Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 379. United States Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 380. Canada Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 381. Canada Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 382. Canada Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 383. Canada Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 384. Mexico Pharmaceutical Intermediates, by Application USD Million (2020-2025)
  • Table 385. Mexico Pharmaceutical Intermediates, by End-User USD Million (2020-2025)
  • Table 386. Mexico Pharmaceutical Intermediates, by Quality Type USD Million (2020-2025)
  • Table 387. Mexico Pharmaceutical Intermediates, by Grade Type USD Million (2020-2025)
  • Table 388. Pharmaceutical Intermediates Sales: by Application(K Tons)
  • Table 389. Pharmaceutical Intermediates Sales Antibiotics , by Region K Tons (2020-2025)
  • Table 390. Pharmaceutical Intermediates Sales Antipyretic Analgesics , by Region K Tons (2020-2025)
  • Table 391. Pharmaceutical Intermediates Sales Vitamins , by Region K Tons (2020-2025)
  • Table 392. Pharmaceutical Intermediates Sales Others , by Region K Tons (2020-2025)
  • Table 393. Pharmaceutical Intermediates Sales: by End-User(K Tons)
  • Table 394. Pharmaceutical Intermediates Sales Pharmaceutical Organizations , by Region K Tons (2020-2025)
  • Table 395. Pharmaceutical Intermediates Sales Research Labs , by Region K Tons (2020-2025)
  • Table 396. Pharmaceutical Intermediates Sales Biotechnology & Life Sciences , by Region K Tons (2020-2025)
  • Table 397. Pharmaceutical Intermediates Sales: by Quality Type(K Tons)
  • Table 398. Pharmaceutical Intermediates Sales Moderate , by Region K Tons (2020-2025)
  • Table 399. Pharmaceutical Intermediates Sales High Quality , by Region K Tons (2020-2025)
  • Table 400. Pharmaceutical Intermediates Sales Premium , by Region K Tons (2020-2025)
  • Table 401. Pharmaceutical Intermediates Sales: by Grade Type(K Tons)
  • Table 402. Pharmaceutical Intermediates Sales Industrial Grade , by Region K Tons (2020-2025)
  • Table 403. Pharmaceutical Intermediates Sales Pharmaceutical Grade , by Region K Tons (2020-2025)
  • Table 404. South America Pharmaceutical Intermediates Sales, by Country K Tons (2020-2025)
  • Table 405. South America Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 406. South America Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 407. South America Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 408. South America Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 409. Brazil Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 410. Brazil Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 411. Brazil Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 412. Brazil Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 413. Argentina Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 414. Argentina Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 415. Argentina Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 416. Argentina Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 417. Rest of South America Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 418. Rest of South America Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 419. Rest of South America Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 420. Rest of South America Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 421. Asia Pacific Pharmaceutical Intermediates Sales, by Country K Tons (2020-2025)
  • Table 422. Asia Pacific Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 423. Asia Pacific Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 424. Asia Pacific Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 425. Asia Pacific Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 426. China Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 427. China Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 428. China Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 429. China Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 430. Japan Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 431. Japan Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 432. Japan Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 433. Japan Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 434. India Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 435. India Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 436. India Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 437. India Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 438. South Korea Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 439. South Korea Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 440. South Korea Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 441. South Korea Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 442. Taiwan Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 443. Taiwan Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 444. Taiwan Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 445. Taiwan Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 446. Australia Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 447. Australia Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 448. Australia Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 449. Australia Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 450. Rest of Asia-Pacific Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 451. Rest of Asia-Pacific Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 452. Rest of Asia-Pacific Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 453. Rest of Asia-Pacific Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 454. Europe Pharmaceutical Intermediates Sales, by Country K Tons (2020-2025)
  • Table 455. Europe Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 456. Europe Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 457. Europe Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 458. Europe Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 459. Germany Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 460. Germany Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 461. Germany Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 462. Germany Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 463. France Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 464. France Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 465. France Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 466. France Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 467. Italy Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 468. Italy Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 469. Italy Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 470. Italy Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 471. United Kingdom Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 472. United Kingdom Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 473. United Kingdom Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 474. United Kingdom Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 475. Netherlands Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 476. Netherlands Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 477. Netherlands Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 478. Netherlands Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 479. Rest of Europe Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 480. Rest of Europe Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 481. Rest of Europe Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 482. Rest of Europe Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 483. MEA Pharmaceutical Intermediates Sales, by Country K Tons (2020-2025)
  • Table 484. MEA Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 485. MEA Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 486. MEA Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 487. MEA Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 488. Middle East Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 489. Middle East Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 490. Middle East Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 491. Middle East Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 492. Africa Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 493. Africa Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 494. Africa Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 495. Africa Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 496. North America Pharmaceutical Intermediates Sales, by Country K Tons (2020-2025)
  • Table 497. North America Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 498. North America Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 499. North America Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 500. North America Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 501. United States Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 502. United States Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 503. United States Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 504. United States Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 505. Canada Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 506. Canada Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 507. Canada Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 508. Canada Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 509. Mexico Pharmaceutical Intermediates Sales, by Application K Tons (2020-2025)
  • Table 510. Mexico Pharmaceutical Intermediates Sales, by End-User K Tons (2020-2025)
  • Table 511. Mexico Pharmaceutical Intermediates Sales, by Quality Type K Tons (2020-2025)
  • Table 512. Mexico Pharmaceutical Intermediates Sales, by Grade Type K Tons (2020-2025)
  • Table 513. Research Programs/Design for This Report
  • Table 514. Key Data Information from Secondary Sources
  • Table 515. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pharmaceutical Intermediates: by Application USD Million (2014-2019)
  • Figure 5. Global Pharmaceutical Intermediates: by End-User USD Million (2014-2019)
  • Figure 6. Global Pharmaceutical Intermediates: by Quality Type USD Million (2014-2019)
  • Figure 7. Global Pharmaceutical Intermediates: by Grade Type USD Million (2014-2019)
  • Figure 8. South America Pharmaceutical Intermediates Share (%), by Country
  • Figure 9. Asia Pacific Pharmaceutical Intermediates Share (%), by Country
  • Figure 10. Europe Pharmaceutical Intermediates Share (%), by Country
  • Figure 11. MEA Pharmaceutical Intermediates Share (%), by Country
  • Figure 12. North America Pharmaceutical Intermediates Share (%), by Country
  • Figure 13. Global Pharmaceutical Intermediates: by Application K Tons (2014-2019)
  • Figure 14. Global Pharmaceutical Intermediates: by End-User K Tons (2014-2019)
  • Figure 15. Global Pharmaceutical Intermediates: by Quality Type K Tons (2014-2019)
  • Figure 16. Global Pharmaceutical Intermediates: by Grade Type K Tons (2014-2019)
  • Figure 17. South America Pharmaceutical Intermediates Share (%), by Country
  • Figure 18. Asia Pacific Pharmaceutical Intermediates Share (%), by Country
  • Figure 19. Europe Pharmaceutical Intermediates Share (%), by Country
  • Figure 20. MEA Pharmaceutical Intermediates Share (%), by Country
  • Figure 21. North America Pharmaceutical Intermediates Share (%), by Country
  • Figure 22. Global Pharmaceutical Intermediates share by Players 2019 (%)
  • Figure 23. Global Pharmaceutical Intermediates share by Players (Top 3) 2019(%)
  • Figure 24. Global Pharmaceutical Intermediates share by Players (Top 5) 2019(%)
  • Figure 25. BCG Matrix for key Companies
  • Figure 26. A.R. Life Sciences Private Limited (India) Revenue, Net Income and Gross profit
  • Figure 27. A.R. Life Sciences Private Limited (India) Revenue: by Geography 2019
  • Figure 28. Vertellus Holdings LLC (United States) Revenue, Net Income and Gross profit
  • Figure 29. Vertellus Holdings LLC (United States) Revenue: by Geography 2019
  • Figure 30. Lianhetech (China) Revenue, Net Income and Gross profit
  • Figure 31. Lianhetech (China) Revenue: by Geography 2019
  • Figure 32. Dishman Group (India) Revenue, Net Income and Gross profit
  • Figure 33. Dishman Group (India) Revenue: by Geography 2019
  • Figure 34. Midas Pharma GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 35. Midas Pharma GmbH (Germany) Revenue: by Geography 2019
  • Figure 36. Codexis, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 37. Codexis, Inc. (United States) Revenue: by Geography 2019
  • Figure 38. Chemcon Specialty Chemicals Pvt. Ltd (India) Revenue, Net Income and Gross profit
  • Figure 39. Chemcon Specialty Chemicals Pvt. Ltd (India) Revenue: by Geography 2019
  • Figure 40. Aceto Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 41. Aceto Corporation (United States) Revenue: by Geography 2019
  • Figure 42. Cycle Pharma (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 43. Cycle Pharma (United Kingdom) Revenue: by Geography 2019
  • Figure 44. Dextra Laboratories Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 45. Dextra Laboratories Ltd. (United Kingdom) Revenue: by Geography 2019
  • Figure 46. BASF SE (Germany) Revenue, Net Income and Gross profit
  • Figure 47. BASF SE (Germany) Revenue: by Geography 2019
  • Figure 48. Sanofi Winthrop Industrie S.A. (France) Revenue, Net Income and Gross profit
  • Figure 49. Sanofi Winthrop Industrie S.A. (France) Revenue: by Geography 2019
  • Figure 50. Global Pharmaceutical Intermediates: by Application USD Million (2020-2025)
  • Figure 51. Global Pharmaceutical Intermediates: by End-User USD Million (2020-2025)
  • Figure 52. Global Pharmaceutical Intermediates: by Quality Type USD Million (2020-2025)
  • Figure 53. Global Pharmaceutical Intermediates: by Grade Type USD Million (2020-2025)
  • Figure 54. South America Pharmaceutical Intermediates Share (%), by Country
  • Figure 55. Asia Pacific Pharmaceutical Intermediates Share (%), by Country
  • Figure 56. Europe Pharmaceutical Intermediates Share (%), by Country
  • Figure 57. MEA Pharmaceutical Intermediates Share (%), by Country
  • Figure 58. North America Pharmaceutical Intermediates Share (%), by Country
  • Figure 59. Global Pharmaceutical Intermediates: by Application K Tons (2020-2025)
  • Figure 60. Global Pharmaceutical Intermediates: by End-User K Tons (2020-2025)
  • Figure 61. Global Pharmaceutical Intermediates: by Quality Type K Tons (2020-2025)
  • Figure 62. Global Pharmaceutical Intermediates: by Grade Type K Tons (2020-2025)
  • Figure 63. South America Pharmaceutical Intermediates Share (%), by Country
  • Figure 64. Asia Pacific Pharmaceutical Intermediates Share (%), by Country
  • Figure 65. Europe Pharmaceutical Intermediates Share (%), by Country
  • Figure 66. MEA Pharmaceutical Intermediates Share (%), by Country
  • Figure 67. North America Pharmaceutical Intermediates Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • A.R. Life Sciences Private Limited (India)
  • Vertellus Holdings LLC (United States)
  • Lianhetech (China)
  • Dishman Group (India)
  • Midas Pharma GmbH (Germany)
  • Codexis, Inc. (United States)
  • Chemcon Specialty Chemicals Pvt. Ltd (India)
  • Aceto Corporation (United States)
  • Cycle Pharma (United Kingdom)
  • Dextra Laboratories Ltd. (United Kingdom)
  • BASF SE (Germany)
  • Sanofi Winthrop Industrie S.A. (France)
Additional players considered in the study are as follows:
ZCL Chemicals Ltd. (India) , Easter Chemical Corporation (United States) , Anyang General Chemical Co., Ltd. (China)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation